Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. SPY
2. TSLA
3. META
4. INTC
5. HOOD
6. STZ
7. AMZN
8. MSFT
9. SPCX
10. GOOGL

Go back to Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
(NASDAQ: XAIR) Delayed: 0.47 --0 (-0%)
Previous Close $0.47    52 Week High $ 
Open $0.46    52 Week Low $ 
Day High $0.48    P/E N/A 
Day Low $0.44    EPS $ 
Volume 185,614